Veracyte, Inc. (VCYT)

Nasdaq Health Care Health Care Services S&P SmallCap 600

$24.16

+0.16 (+0.67%)

Close of Nov 06, 2026 · end-of-day data

Source: Veracyte, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$65.08M	$71.95M	$92.01M	$120.37M	$117.48M	$219.51M	$296.54M	$361.05M	$445.76M	$517.14M
Cost of revenue	$25.46M	$28.20M	$33.08M	$36.08M	—	—	—	—	—	—
Gross profit	$39.62M	$43.76M	$58.93M	$84.29M	—	—	$175.68M	$229.68M	$298.14M	$362.53M
Research & development	$15.32M	$13.88M	$14.82M	$14.85M	$17.20M	$29.84M	$40.60M	$57.30M	$69.29M	$70.81M
Operating income	-$28.80M	-$26.54M	-$22.23M	-$15.13M	-$35.39M	-$81.90M	-$41.08M	-$85.80M	$16.14M	$57.78M
Interest expense	$2.76M	$4.94M	$1.96M	$677.00K	$229.00K	—	—	—	—	—
Pre-tax income	-$31.40M	-$31.00M	-$23.00M	-$12.60M	-$34.91M	-$81.65M	-$36.43M	-$76.61M	$25.74M	$68.20M
Income tax	$0	$0	$0	$0	$0	-$6.09M	$133.00K	-$2.21M	$1.61M	$1.85M
Net income	-$31.36M	-$31.00M	-$23.00M	-$12.60M	-$34.91M	-$75.56M	-$36.56M	-$74.40M	$24.14M	$66.35M
EBITDA	-$25.29M	-$22.70M	-$18.31M	-$11.01M	-$27.45M	-$62.31M	-$15.15M	-$58.61M	$39.60M	$79.19M
EPS (basic)	$-1.09	$-0.91	$-0.62	$-0.27	$-0.66	$-1.11	$-0.51	$-1.02	$0.32	$0.84
EPS (diluted)	$-1.09	$-0.91	$-0.62	$-0.27	$-0.66	$-1.11	$-0.51	$-1.02	$0.31	$0.82
Diluted shares	28.83M	33.93M	37.02M	46.14M	53.24M	67.89M	71.55M	72.64M	78.16M	80.57M
Gross margin	60.9%	60.8%	64.0%	70.0%	—	—	59.2%	63.6%	66.9%	70.1%
Operating margin	-44.3%	-36.9%	-24.2%	-12.6%	-30.1%	-37.3%	-13.9%	-23.8%	3.6%	11.2%
Net margin	-48.2%	-43.1%	-25.0%	-10.5%	-29.7%	-34.4%	-12.3%	-20.6%	5.4%	12.8%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$59.22M	$33.89M	$78.00M	$159.32M	$349.36M	$173.20M	$154.25M	$216.45M	$239.09M	$362.58M
Short-term investments	—	—	—	—	—	—	—	—	—	$50.31M
Receivables	$8.76M	$12.72M	$13.17M	$19.33M	$18.46M	$41.46M	$44.02M	$40.38M	$46.52M	$44.66M
Inventory	$3.48M	$5.32M	$3.40M	$6.81M	$4.66M	$11.22M	$14.29M	$16.13M	$21.75M	$20.55M
Total current assets	$73.63M	$53.93M	$96.95M	$187.69M	$375.68M	$243.10M	$248.64M	$285.62M	$372.27M	$488.38M
Goodwill	$1.06M	$1.06M	$1.06M	$2.73M	$2.73M	$707.90M	$695.89M	$702.98M	$745.80M	$767.15M
Total assets	$101.03M	$78.67M	$120.64M	$275.21M	$457.16M	$1.19B	$1.16B	$1.11B	$1.30B	$1.41B
Total current liabilities	$11.53M	$12.03M	$13.06M	$17.47M	$16.78M	$64.15M	$62.61M	$61.24M	$78.63M	$59.94M
Short-term debt	—	$0	$1.36M	$0	$0	$1.13M	$0	—	—	—
Long-term debt	$24.92M	$24.94M	$23.93M	$694.00K	$810.00K	$0	—	—	—	—
Total debt	$24.92M	$24.94M	$25.28M	$694.00K	$810.00K	$1.13M	$0	—	—	—
Total liabilities	$41.45M	$41.44M	$40.88M	$35.76M	$35.93M	$91.31M	$81.22M	$70.80M	$124.07M	$96.44M
Shareholders' equity	$59.58M	$37.23M	$79.75M	$239.46M	$421.23M	$1.10B	$1.08B	$1.04B	$1.18B	$1.31B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$27.98M	-$23.91M	-$13.52M	-$3.23M	-$9.71M	-$31.62M	$7.54M	$44.22M	$75.10M	$136.31M
Capital expenditures	$4.21M	$1.75M	$1.87M	$2.76M	$2.84M	$5.38M	$8.55M	$9.96M	$11.29M	$9.68M
Free cash flow	-$32.19M	-$25.67M	-$15.39M	-$5.99M	-$12.55M	-$37.00M	-$1.01M	$34.26M	$63.81M	$126.63M
Investing cash flow	-$4.21M	-$1.31M	-$1.87M	-$42.73M	-$3.84M	-$739.21M	-$29.39M	$15.11M	-$56.27M	-$9.21M
Financing cash flow	$52.33M	-$218.00K	$59.50M	$127.29M	$203.59M	$596.32M	$3.49M	$2.84M	$4.90M	-$4.22M
Stock-based compensation	$6.38M	$6.62M	$5.96M	$9.81M	$12.99M	$22.52M	$26.73M	$33.14M	$36.25M	$43.60M
Depreciation & amortization	$3.51M	$3.84M	$3.92M	$4.12M	$7.94M	$19.59M	$25.93M	$27.19M	$23.46M	$21.41M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$98.20M	$96.84M	$114.43M	$115.86M	$118.63M	$114.47M	$130.16M	$131.87M	$140.64M	$139.07M	$150.32M	$151.75M
Gross profit	$64.79M	$62.47M	$77.91M	$79.01M	$78.75M	$79.51M	$89.77M	$91.28M	$101.97M	$101.16M	$108.55M	$107.10M
Research & development	$18.67M	$15.96M	$16.46M	$17.57M	$19.29M	$17.72M	$16.26M	$15.98M	$20.85M	$27.10M	$29.44M	$32.16M
Operating income	-$35.51M	-$4.66M	$4.61M	$12.02M	$4.17M	$2.90M	-$5.27M	$22.95M	$37.20M	$22.65M	$22.98M	$16.57M
Pre-tax income	-$30.47M	-$1.91M	$7.36M	$16.85M	$3.44M	$7.43M	$1.25M	$18.89M	$40.63M	$29.97M	$26.52M	$21.12M
Income tax	-$2.18M	-$44.00K	$1.63M	$1.69M	-$1.67M	$381.00K	$2.23M	-$248.00K	-$515.00K	$1.27M	$1.03M	-$10.38M
Net income	-$28.29M	-$1.86M	$5.73M	$15.15M	$5.11M	$7.05M	-$980.00K	$19.14M	$41.15M	$28.71M	$25.49M	$31.50M
EBITDA	-$29.17M	$934.00K	$10.34M	$17.89M	$10.43M	$8.27M	$221.00K	$28.21M	$42.49M	$28.08M	$27.82M	$22.55M
EPS (basic)	$-0.38	$-0.02	$0.07	$0.20	$0.07	$0.09	$-0.01	$0.24	$0.52	$0.36	$0.32	$0.39
EPS (diluted)	$-0.38	$-0.02	$0.07	$0.19	$0.06	$0.09	$-0.01	$0.24	$0.50	$0.35	$0.31	$0.38
Diluted shares	155.89K	74.76M	77.16M	78.46M	823.32K	80.06M	78.39M	79.69M	626.75K	81.31M	82.06M	82.78M
Gross margin	66.0%	64.5%	68.1%	68.2%	66.4%	69.5%	69.0%	69.2%	72.5%	72.7%	72.2%	70.6%
Operating margin	-36.2%	-4.8%	4.0%	10.4%	3.5%	2.5%	-4.0%	17.4%	26.4%	16.3%	15.3%	10.9%
Net margin	-28.8%	-1.9%	5.0%	13.1%	4.3%	6.2%	-0.8%	14.5%	29.3%	20.6%	17.0%	20.8%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$216.45M	$209.19M	$235.91M	$274.08M	$239.09M	$186.12M	$219.50M	$315.57M	$362.58M	$263.14M	$299.52M	$199.83M
Short-term investments	—	—	—	—	—	—	—	—	$50.31M	—	—	—
Receivables	$40.38M	$46.66M	$50.30M	$48.81M	$46.52M	$53.78M	$50.81M	$47.83M	$44.66M	$50.11M	$54.18M	$56.79M
Inventory	$16.13M	$18.33M	$19.26M	$20.36M	$21.75M	$24.25M	$25.02M	$20.33M	$20.55M	—	—	—
Total current assets	$285.62M	$290.42M	$321.11M	$356.85M	$372.27M	$383.15M	$414.68M	$449.22M	$488.38M	$522.17M	$574.77M	$467.88M
Goodwill	$702.98M	$753.85M	$752.11M	$762.12M	$745.80M	$754.27M	$773.25M	$767.15M	$767.15M	$767.15M	$767.15M	$855.58M
Total assets	$1.11B	$1.20B	$1.23B	$1.28B	$1.30B	$1.32B	$1.34B	$1.37B	$1.41B	$1.44B	$1.49B	$1.57B
Total current liabilities	$61.24M	$58.05M	$72.34M	$70.31M	$78.63M	$75.12M	$76.43M	$72.15M	$59.94M	$56.12M	$62.74M	$84.21M
Total liabilities	$70.80M	$81.42M	$101.80M	$98.98M	$124.07M	$120.47M	$123.05M	$110.12M	$96.44M	$91.99M	$97.96M	$139.99M
Shareholders' equity	$1.04B	$1.12B	$1.13B	$1.18B	$1.18B	$1.19B	$1.22B	$1.26B	$1.31B	$1.34B	$1.39B	$1.43B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$15.55M	-$8.97M	$29.57M	$29.96M	$24.52M	$5.36M	$33.60M	$44.76M	$52.58M	$35.22M	$45.83M	$40.26M
Capital expenditures	$2.50M	$2.13M	$2.77M	$2.24M	$4.14M	$1.82M	$1.29M	$2.79M	$3.78M	$2.96M	$2.86M	$2.33M
Free cash flow	$13.05M	-$11.10M	$26.80M	$27.72M	$20.38M	$3.54M	$32.32M	$41.97M	$48.80M	$32.25M	$42.97M	$37.92M
Investing cash flow	-$2.50M	$2.88M	-$2.77M	-$2.24M	-$54.14M	-$51.82M	-$224.00K	$48.26M	-$5.43M	-$127.96M	-$13.54M	-$139.47M
Financing cash flow	$645.00K	-$864.00K	-$11.00K	$10.29M	-$4.51M	-$6.48M	-$566.00K	$2.98M	-$149.00K	-$6.63M	$4.14M	-$479.00K
Stock-based compensation	$7.51M	$8.02M	$9.85M	$8.75M	$9.63M	$10.96M	$10.98M	$10.76M	$10.90M	$12.76M	$14.09M	$13.96M
Depreciation & amortization	$6.34M	$5.59M	$5.74M	$5.88M	$6.25M	$5.36M	$5.49M	$5.27M	$5.30M	$5.43M	$4.84M	$5.98M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.